BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 25577298)

  • 21. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of cancer risk assessment and counseling related to psychological, financial and legal implications.
    Snyder C
    Fam Cancer; 2016 Jul; 15(3):493-6. PubMed ID: 26920353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stakeholder Perspectives on Overcoming Barriers to Cascade Testing in Lynch Syndrome: A Qualitative Study.
    Srinivasan S; Hampel H; Leeman J; Patel A; Kulchak Rahm A; Reuland DS; Roberts MC
    Cancer Prev Res (Phila); 2020 Dec; 13(12):1037-1046. PubMed ID: 32727822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.
    Katapodi MC; Viassolo V; Caiata-Zufferey M; Nikolaidis C; Bührer-Landolt R; Buerki N; Graffeo R; Horváth HC; Kurzeder C; Rabaglio M; Scharfe M; Urech C; Erlanger TE; Probst-Hensch N; Heinimann K; Heinzelmann-Schwarz V; Pagani O; Chappuis PO
    JMIR Res Protoc; 2017 Sep; 6(9):e184. PubMed ID: 28931501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Current Practice of Lynch Syndrome Diagnosis and Management in Italy: A Qualitative Assessment.
    Tognetto A; Pastorino R; Castorina S; Condorelli DF; DeCensi A; De Vito C; Magnano A; Scaldaferri F; Villari P; Genuardi M; Boccia S
    Public Health Genomics; 2019; 22(5-6):189-207. PubMed ID: 31805557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
    Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C
    Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes of a genomic screening program for actionable genetic conditions.
    Buchanan AH; Lester Kirchner H; Schwartz MLB; Kelly MA; Schmidlen T; Jones LK; Hallquist MLG; Rocha H; Betts M; Schwiter R; Butry L; Lazzeri AL; Frisbie LR; Rahm AK; Hao J; Willard HF; Martin CL; Ledbetter DH; Williams MS; Sturm AC
    Genet Med; 2020 Nov; 22(11):1874-1882. PubMed ID: 32601386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening Families of North Texans to Identify Persons with an Increased Risk for Cancer Due to Lynch Syndrome.
    Ross T; Pirzadeh-Miller S; Lahiri S; Gemmell A
    Tex Med; 2019 Dec; 115(12):e1. PubMed ID: 31800088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
    Stoffel EM; Mangu PB; Gruber SB; Hamilton SR; Kalady MF; Lau MW; Lu KH; Roach N; Limburg PJ; ;
    J Clin Oncol; 2015 Jan; 33(2):209-17. PubMed ID: 25452455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Communicating risk with relatives in a familial hypercholesterolemia cascade screening program: a summary of the evidence.
    Allison M
    J Cardiovasc Nurs; 2015; 30(4):E1-E12. PubMed ID: 24831729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia.
    Langslet G; Ose L
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1061-6. PubMed ID: 23984929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian Cancer in Hereditary Cancer Susceptibility Syndromes.
    Nakonechny QB; Gilks CB
    Surg Pathol Clin; 2016 Jun; 9(2):189-99. PubMed ID: 27241103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Familial hypercholesterolemia: why screening, counselling and treatment should be integrated].
    Roeters van Lennep JE; Visseren FL; Jira PE
    Ned Tijdschr Geneeskd; 2015; 159():A8875. PubMed ID: 26013253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes from a pilot genetic counseling intervention using motivational interviewing and the extended parallel process model to increase cascade cholesterol screening.
    Baldry E; Redlinger-Grosse K; MacFarlane I; Walters ST; Ash E; Steinberger J; Murdy K; Cragun D; Allen-Tice C; Zierhut H
    J Genet Couns; 2022 Feb; 31(1):164-175. PubMed ID: 34260792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotype-guided diagnosis in familial hypercholesterolemia: population burden and cascade screening.
    Hopkins PN
    Curr Opin Lipidol; 2017 Apr; 28(2):136-143. PubMed ID: 28030379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Universal Screening of Colorectal Cancers for Lynch Syndrome: Challenges and Opportunities.
    Vindigni SM; Kaz AM
    Dig Dis Sci; 2016 Apr; 61(4):969-76. PubMed ID: 26602911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relatives from Hereditary Breast and Ovarian Cancer and Lynch Syndrome Families Forgoing Genetic Testing: Findings from the Swiss CASCADE Cohort.
    Sarki M; Ming C; Aceti M; Fink G; Aissaoui S; Bürki N; Graffeo R; Heinimann K; Caiata Zufferey M; Monnerat C; Rabaglio M; Zürrer-Härdi U; Chappuis PO; Katapodi MC; The Cascade Consortium
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.
    Frolova AI; Babb SA; Zantow E; Hagemann AR; Powell MA; Thaker PH; Gao F; Mutch DG
    Gynecol Oncol; 2015 Apr; 137(1):7-13. PubMed ID: 25617771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.